Discontinued — last reported Q4 '25
General Electric Equity Method Investments increased by 1.7% to $38.79B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.8%, from $37.74B to $38.79B. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 39.6% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $329.00M | $366.00M | $7.39B | $528.00M | $664.00M | $728.00M | $7.82B | $714.00M | $786.00M | $909.00M | $7.93B | $38.71B | $38.13B | $39.51B | $37.74B | $38.01B | $37.89B | $38.16B | $38.79B |
| QoQ Change | — | +11.2% | >999% | -92.9% | +25.8% | +9.6% | +973.5% | -90.9% | +10.1% | +15.6% | +772.5% | +388.0% | -1.5% | +3.6% | -4.5% | +0.7% | -0.3% | +0.7% | +1.7% |
| YoY Change | — | — | — | — | +101.8% | +98.9% | +5.7% | +35.2% | +18.4% | +24.9% | +1.5% | >999% | >999% | >999% | +375.9% | -1.8% | -0.6% | -3.4% | +2.8% |